Gastroenterology and Liver

Cholangiocarcinoma Research

Cholangiocarcinoma, a rare but aggressive biliary tract malignancy, demands early detection and innovative management strategies. This session will explore molecular mechanisms, genetic mutations, and tumor microenvironment interactions that drive disease progression. Participants will review advancements in diagnostic imaging, biomarker discovery, and histopathological evaluation for improved early detection and risk stratification. Therapeutic innovations, including surgical interventions, targeted therapies, immunotherapy, and combined modality approaches, will be presented to enhance survival and clinical outcomes.

The track also emphasizes collaborative research and multidisciplinary care models in managing cholangiocarcinoma. Case discussions, clinical trials, and translational research findings will be shared to highlight real-world challenges and solutions. Participants will explore future directions, including precision medicine approaches, novel systemic agents, and patient-specific treatment planning. This session provides an ideal platform for researchers, clinicians, and healthcare professionals to exchange knowledge, present their work, and contribute to improving outcomes for cholangiocarcinoma patients.